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Abstract  
Background 
We conducted a survey to identify what types of health/medical research could be exempt from 
research ethics reviews in Australia.  
Methods 
We surveyed Australian health/medical researchers and Human Research Ethics Committee (HREC) 
members. The survey asked whether respondents had previously changed or abandoned a project 
anticipating difficulties obtaining ethics approval, and presented 8 research scenarios, asking 
whether these scenarios should or should not be exempt from ethics review, and to provide 
(optional) comments. Qualitative data were analysed thematically; quantitative data in R. 
Results:  
We received 514 responses. Forty-three percent of respondents to whom the question applied, 
reported changing projects in anticipation of obstacles from the ethics review process; 25% reported 
abandoning projects for this reason. Research scenarios asking professional staff to provide views in 
their area of expertise  were most commonly exempted from ethics review (to prioritise systematic 
review topics 84%, on software strengths/weaknesses 85%); scenarios involving surplus samples 
(82%) and N-of-1 (single case) studies (76%) were most commonly required to undergo ethics 
review. HREC members were 26% more likely than researchers to require ethics review.  Need for 
independent oversight, and low risk, were most frequently cited in support of decisions to require or 
exempt from ethics review, respectively.  
Conclusions 
Considerable differences exist between researchers and HREC members, about when to exempt 
from review the research that ultimately serves the interests of patients and the public. It is widely 
accepted that evaluative research should be used to reduce clinical uncertainties – the same 




Ethics oversight of research is necessary and desirable to protect research participant from excessive 
physical or psychological risks, or undue burden associated with participation in research. It is 
increasingly acknowledged that a “one-size-of-ethics-review-fits-all” type of evaluation is 
inappropriate, and that ethics reviews could be streamlined by developing more risk-proportionate 
and flexible processes.(1, 2) Disproportionate regulation of research – for example, the requirement 
for low-risk or negligible-risk research to undergo full ethics review – imposes considerable time and 
cost burdens on researchers and members of research ethics committees.(3, 4) More importantly, it 
compromises the interests of patients – research hindered or abandoned due to disproportionate 
regulation can delay the identification of low-value care – that is, care that provides little or no 
benefit to patients(5) – and adverse and beneficial effects of treatments.(6) In extreme cases, these 
delays can even be lethal, as shown, for example, by the analysis of the CRASH Trial data, which 
found that delayed administration of treatment within a trial context (due to fulfillment of consent 
requirements) increased the patients’ relative risk of death. (7)  
Considerable international variation exists in how authorities apply – or do not apply – risk -
proportionate review processes. For example, a seven-country trial of a leaflet intended to improve 
older patients’ involvement in general practitioner consultations was deemed not to require ethics 
review in 4 countries but required full ethics review in 3 other countries.(8) This "ethics review 
roulette" is manifested in wide variation of national ethics guidance across different countries.(9) A 
recent comparison of research ethics review requirements in four countries found that research 
involving only re-use of publicly available data sets (such as aggregated registry data) is always 
exempt, but that considerable variation exists for other types of research. For example, surveys of 
professional staff aimed at improving professional practice were exempt in some but not all 
countries, and three of the four countries exempt questionnaire or survey research, albeit subject to 
stipulated conditions such as minimal inconvenience.(10) A recent petition to the Australian 
government further highlighted the problems faced by Australian researchers when navigating 
research ethics processes. Many of the over 400 comments prompted by the petition emphasised 
that “the overburden of bureaucracy in research is harmful to patients” and that a better system 
“would mean more efficient and better quality outcomes for patients.”(11) 
We report here the results of a survey designed to explore the perceptions of Australian 
health/medical researchers and members of Australian research ethics committees on how the 
Australian research ethics system might serve the interests of patients more effectively. Specifically, 
we wished to identify which types of research might be exempted from ethics review because the 
risks theoretically associated with them are minimal or non-existent.    
Methods 
This survey is reported following the Checklist for Reporting Results of Internet E-Surveys 
(CHERRIES) reporting guideline.(12)  
Sample 
Our survey targeted active human health and medical researchers and members of Human Research 
Ethics Committees (HRECs) in Australia (i.e., it was a “closed survey”, limited only to a known sample 
rather than open to everyone to complete)  
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Australian researchers were identified by searching PubMed for publications between 1 April 2019 
and 30 June 2019 for which the corresponding author’s affiliation field contained the words 
“Australia” OR “Australian.” The resulting references (n=4956) were exported to EndNote. The 
author address field was then searched for the term “.au”. From these, a sample of 900 emails and 
names was randomly selected (by AB). 
A list of 208 Australian HRECs which is maintained by the National Health and Medical Research 
Council(13) was used to obtain contact information for the HREC’s Administrator (or alternatively 
Chair or Manager). Where no website was provided, we attempted to identify contact information 
using web searches.  We identified contact information for 175 of the 208 committees in the list.  
Survey instrument 
Our survey instrument had 3 parts (see Appendix 1): 
• Part 1 (page 1 of the survey): consisted of a demographic question that asked whether the
respondent was (i) a human health/medical researcher at an Australian institution; (ii) a
former or current member of an Australian human research ethics committee; or (iii) both of
the above.
• Part 2 (page 2 of the survey): asked whether the respondent had previously changed or
abandoned a research project in anticipation of difficulty in obtaining ethics approval.
• Part 3 (pages 3-11 of the survey): presented eight hypothetical research scenarios and
respondents were asked for each whether it should be exempt or not exempt from ethics
review in Australia. Respondents were also invited to suggest other research scenarios that
could be exempted from ethics review in Australia.
Six of the eight hypothetical research scenarios in Part 3 were derived from an earlier project, 
comparing the types of research exempt from ethics review in Australia, the United States, the 
United Kingdom, and The Netherlands(10); two scenarios (Linked Data Sets and N-of-1 (single case) 
studies) were suggested for inclusion by colleagues who had previously experienced challenges with 
ethics reviews for those types of research. 
We piloted the survey with two colleagues who were otherwise not involved in the project. As the 
time required for completion proved too burdensome (30 to 40 minutes) we shortened Part 3 of the 
survey from 8 to 4 research scenarios. However, to still obtain views on all 8 hypothetical research 
scenarios, we generated four versions of the survey (each containing 4 scenarios) for random 
distribution among respondents. The resulting survey consisted of 7 pages. The sequence of 
scenarios was held constant in each survey version – adaptive questioning was not used – but 
respondents were able to review and change prior answers. (See Appendix 2) 
Survey allocation 
The survey was disseminated to active researchers by email. Each email contained a brief 
introduction to the project and a link to the survey. The survey was hosted on the SurveyMonkey 
platform. Researchers were randomly allocated one of the four survey versions (A, B, C or D), so the 
final sample would include a similar number of answers across all the scenarios.  
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A contact at each HREC was also randomly allocated one of the four survey versions (named H1, H2, 
H3, H4 – these versions corresponded to researcher survey versions A, B, C, D, respectively. The 
different naming convention was used to enable separate tracking of the response rates for the 
HRECs and the researchers). Each HREC contact was asked to distribute the received link to the same 
survey version (H1, or H2, or H3, or H4) to all their members. This was for logistical reasons, because 
we did not have the contact emails of the individual committee members.  
Survey dissemination process 
The survey was disseminated to researchers in two batches: 295 researchers were contacted on 10 
September 2019, and 522 researchers were contacted on 23 September 2019 (each group was sent 
an email reminder a week later). The survey was disseminated to 175 HREC contacts on 26 
September 2019, with an email reminder a week later. 
All survey responses were eligible for inclusion if returned before 1 November 2019.  
Analyses 
Quantitative data were analysed using R (Version 4.0.0). We estimated the probability of answering 
that ethics was required using a Bayesian logistic regression model, with fixed effects for respondent 
type (i.e. researcher only, member of HREC only, both a researcher and HREC member) and random 
effects for respondents, survey version and scenario. We used vague normal priors for means and 
Gamma(1,1) priors for precisions. We visually checked the convergence of the chains and compared 
the estimated probabilities with the observed. The results are presented as the estimated mean 
probability of answering that ethics is required together with 95% credible intervals. The code to 
create the quantitative analysis is publicly available (https://github.com/agbarnett/ethics_survey). 
Qualitative data were analysed using Excel or NVivo. All of the survey questions (excepting the 
demographic question) provided respondents with the option to add a comment or further 
explanation. These were analysed thematically, using an inductive approach.(14) Coding was 
conducted by two researchers; a third compared the two sets of themes, and rephrased or 
amalgamated for consistency. Here, we briefly report commonly raised themes underpinning the 
decisions that a scenario should (or should not) be exempt, together with sample quotes (a fuller 
discussion of the themes will be reported elsewhere). We corrected minor typographical errors in 
the quotes but otherwise made no changes. 
Ethics approval and informed consent 
[Blinded for peer review] Human Research Ethics Committee provided approval for the project 
(32214912). The first page of the survey provided information about the survey content and its aims, 
privacy, data protection, and consent. Participation and completion were voluntary. No incentives 
for completion were offered. 
Patient and public involvement 




We received 514 survey responses in total (from both researcher respondents and HREC 
respondents).  
Of the randomly selected sample of 900 researcher emails, 817 successfully received the emails (i.e. 
the emails did not bounce as erroneous, no longer valid, etc.), and we received 172 responses 
(response rate 21%).  
175 HRECs with available contact email were contacted to disseminate the surveys (versions H1 to 
H4). We received 342 responses, for an estimated maximum response rate of 24%. (The maximal 
response rate assumes 175 HRECs of 8 members, which is the minimum number of members on an 
HREC stipulated by the NHMRC; the response rate may be lower, as HRECs may have more than 8 
members). (see Figure 1) 
[insert figure 1 here] 
Respondents  
The median time to complete the survey was 10 minutes (inter-quartile range: 5 to 19 minutes).  
Of the 514 responses, 153 were from researchers, 196 were from HREC members, and 163 from 
individuals who identified themselves as both researchers and HERC members. Two respondents did 
not identify their status. Responses by survey version and respondent type are summarised in Figure 
1.  
Analysis 
Changes made to research projects  
Condensed description of the survey question: I have changed a project from what I had originally 
envisioned (e.g. changed methods, population) because I was concerned about applying for and 
obtaining ethics approval (time, complexity, etc.) (for a full description, see Appendix 1) 
Of 514 responses to this question: 139 said Yes (27%), 188 said No (37%), 161 stated that this 
question did not apply to them (31%), and 26 (5%) did not respond.  
Of all valid responses (that is, of Yes and No responses only, n=327): 43% said Yes, and 57% said No. 
(for percentage of both valid responses and all responses to each survey question, see Appendix 4). 
53 respondents provided comments explaining the changes they had made. 
Methods: Respondents reported making changes to outcome measures (e.g. to one considered less 
invasive), type of study (e.g., to an audit activity with an ethics waiver or to a non-qualitative design), 
study phase (from phase 2 to phase 1 trial), or recruitment methods (no detail provided). One 
researcher “decided to drop a suicide measure and just use a depression measure.” Another “wanted 
to change a trial from Phase 1 to Phase 2 before the Ethics Approval Expired... […] However, we 
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changed it back to a phase 1 because of the requirements by our ethics would [have] created a great 
deal of extra work.” Research methods were altered so that a project could be classified as a 
low/negligible risk rather than higher risk, to avoid a full ethics review. One respondent mentioned 
that “If resources and timeframes are tight, I have had to be pragmatic about lowering the risk of the 
study (e.g. not asking for identifying information or using secondary data sources with their 
limitations).” Another “altered research methods so that project could be classified as LNR 
[low/negligible risk] and avoid full ethics review.”  
Study population: Respondents excluded population groups from studies if they believed that 
including these groups would elevate the level of study risk or extend the time required for ethics 
review. Respondents reported “Avoiding obtaining data from certain groups e.g. those under 18 
years old, pregnant women, Indigenous peoples, and those with disability” or “[e]xcluded analysis of 
Aboriginal people as [it’s] too hard to get Aboriginal ethics approval” or “chosen a different 
population to avoid [a] difficult ethics committee and be able to go through a more sensible 
committee.” 
Number of centres: Changes were made from multi-site to fewer- or single-site projects to reduce 
the number of HRECs involved. One respondent stated doing so “chiefly in the interest of timeliness -
- reducing the number of HRECs involved, especially avoiding those known to have few sittings a year 
and very long lead times, so that projects are viable within the funding period has been critical.” 
Another mentioned that on “several occasions [we] conducted single centre projects, where it would 
have been better to involve willing collaborators at other sites, solely because of the complexity and 
delay associated with multi-site ethics review for very low risk projects.” 
Study personnel: Individuals were excluded as study personnel, or a researcher’s role was modified 
to expedite ethics review. For example, a respondent stated: “I am an Aboriginal researcher 
undertaking Aboriginal community health research in my own community. The HREC regarded my 
situation as a conflict of interest, so I changed my ethics application status from CI-A [Chief 
Investigator A] to CI-D [Chief Investigator D] so I could continue to engage with my own community.” 
Another “did not include research student as investigator with access to identifiable data as timely 
additional agreements would be required.” 
Abandoned research projects 
Condensed description of the survey question: I abandoned a project I had intended to conduct 
because I was concerned about applying for and obtaining ethics approval (time, complexity, etc.) 
Of 514 responses to this question: 81 (16%) of all respondents answered Yes; 242 (47%), answered 
No; 165 (32%) said the question did not apply to them; and 26 (5%) gave no answer. 
Of all valid responses (that is, Yes and No responses only, n=323): 25% of respondents answered Yes, 
and 75% of respondents answered No.   
32 respondents provided information on the types of projects abandoned, or the reasons for 
abandoning them.  
Types of projects: Among abandoned studies were those conducted by research students, including 
a “Master's student project – LNR [low/negligible risk] but knew there was no way of getting it 
through ethics in time.” More generally, another responder commented, student research projects 
“often struggle to obtain timely ethics approvals.”  
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Studies conducted with specific groups were also mentioned, for example, “prospective studies in 
patients not able to give consent.” Another commenter noted that “the ethics approval took 20 
months on a trial which was meant to help terminally ill cancer patients. In the end we had to send 
the funding back.” 
Reasons provided for abandoning the projects: Burdensome nature of the application processes 
was cited as reason for abandoning studies – for example, “Simple case reports and retrospective 
case series were abandoned because of the time and complexity in applying for ethics approval”. The 
burdensome processes were also offered as a more general reason underpinning disinclination to do 
research “Current processes for low risk are so cumbersome at my local health service: 100 page 
submission that still needs to be signed off by CEO of hospital even for low risk with site governance 
from another committee! Makes me less inclined to do any research with that organisation.” 
“Expense, especially expense in time” was also offered as a reason for abandoning studies. 
Incompatibility with funding timelines was also cited. One respondent mentioned they “couldn't 
secure ethics in time for funding deadline,” and another “needed to return a grant due to delays in 
ethics and governance.”  Another respondent mentioned that “many projects I have been involved 
with have been abandoned because the ethics approval process takes too long and is too laborious, 
especially for junior researchers.” 
Scenario 1: N-of-1 (single case) studies in clinical practice 
Condensed description of the survey scenario: A GP has noticed that some of her patients complain 
about side effects of a drug. The GP randomises 20 of her patients, to 2 weeks on a placebo and 2 
weeks on the medication. The ordering is concealed. All patients consent and keep records of their 
symptoms. The GP wishes to publish her findings.  
Of 213 responses to this question: 51 (24% of valid responses) respondents stated this scenario 
should not require ethics review, and 162 (76%) respondents stated this scenario should require 
ethics review (for percentage of both all responses and of valid responses, see Appendix 4). 162 
respondents left a comment detailing the reasons for the decision for not requiring (or requiring) 
ethics review. 
Reasons for exempting the scenario: The most frequently mentioned reason for exempting this 
scenario was that it describes standard clinical practice or routine care (25 respondents) – a “part of 
necessary treatment/investigations for the patient.” Some respondents (n=6) also noted that “risks 
are minimal” in this scenario.  
Reasons for requiring ethics review for the scenario: Respondents who required an ethics review for 
this scenario, emphasised that it requires independent oversight (84 respondents): “this is research, 
and requires oversight.” Others required ethics review on the grounds that it needs a review for 
scientific rigour (n=34) – particularly the need to review the “design, statistics, to ensure adequate 
power.” Others (n=18) linked their decision to issues around publishing – one stating that “The 
criteria that pushes this over a threshold for ethics review is the desire to publish and disseminate the 
research further.” Finally, some (n=12) highlighted the privacy issues, stating that as the scenario 
“includes private health information of an individual,” ethics review should be required.  
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Scenario 2: No treatment/no behavioural rules imposed 
Condensed description of the survey scenario: Study of any design (cohort, randomised control 
trial, others) that does not require participants to receive any treatment that is not already in 
routine use, and does not require participants to follow any behavioural rules that are not already 
applied in routine care. 
Of 250 responses to this question: 124 (50%) respondents stated this scenario should not require 
ethics review, and 126 (50%) respondents stated this scenario should require ethics review. 181 
respondents left a comment detailing the reasons for their decision. 
Reasons for exempting the scenario: Decisions to exempt the scenario frequently emphasised that 
the scenario represents standard clinical care or routine practice (55 respondents), noting that 
“nothing is being done that would not be done anyway, except, basically, counting.” Others referred 
to the study design (n=32), describing the scenario as a “clinical audit” or a “quality improvement 
program.” Several also advocated either an altogether exemption or a minimal review (n=4): “it 
could be done with either no review or with a rapid, low level review.”  
Reasons for requiring ethics review for the scenario: Those requiring an ethics review, noted that 
the scenario requires independent oversight (64 respondents) – “ethics [review] process provides 
oversight to ensure that appropriate safeguards are in place.” Many others (n=33) grounded their 
decision in a need for a review of scientific rigour, highlighting that “the HREC review also considers 
the methodology, whether the study has sufficient statistical power to detect an effect etc.” Some 
respondents (n=20) based their decision on privacy issues, as in the scenario, “personal medical 
records are being accessed.”  
Scenario 3: Linked data sets (‘big data’ population health research) 
Condensed description of the survey scenario: A study involving the use of linked, de-identified 
administrative data sets (e.g. registries, electronic health records). Data centre holding the original 
data set assessed the project for privacy issues, feasibility, adequacy of data set creation and 
analysis. Data sets were held in a secured facility, and individual data could not be seen. Analyses on 
the linked sets could be performed but not downloaded, nor could the data be downloaded. 
Of 192 responses to this question: 126 (66%) respondents stated this scenario should not require 
ethics review, and 66 (34%) respondents stated this scenario should require ethics review. 119 
respondents left a comment detailing the reasons for their decision. 
Reasons for exempting the scenario: Respondents who thought the scenario should not require 
ethics review, frequently did so based on the level of risk involved (43 respondents), describing the 
scenario as posing an “inconceivable risk”. Many (n=25) did so on the grounds that ethical 
considerations had previously been addressed, noting that “If there were no ethical concerns prior to 
or throughout the study and there is no identifiable data, there is no reason for further ethical 
review.” Several (n=4) also suggested that some type of a project review could be appropriate but 
not a full ethics review, as this type of research “needs clear accountability, transparency re access 
but not sure that ethics committee is correct route for this.”    
Reasons for requiring ethics review for the scenario: Respondents who thought this scenario 
requires an ethics review most frequently cited the need for independent oversight (21 
respondents), as it ”reassures patients whose data is used that an independent body had oversight 
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and considered [t]he risks to them.” Others (n=15) raised privacy and confidentiality concerns, noting 
that the “potential for reidentification is relevant.” The ethics review’s role in reviewing projects for 
scientific rigour was also raised (n=6), as this scenario “requires evaluation of scientific merit.”  
Scenario 4: Surplus samples or tissues during routine collection in clinical 
practice 
Condensed description of the survey scenario: Research may use surplus (extra) tissue or samples 
obtained from people during routine medical procedures (e.g. extra blood at time of sampling, or 
tissue not required for diagnosis/testing.  
Of 232 responses to this question: 41 (18%) respondents stated this scenario should not require 
ethics review, and 191 (82%) respondents stated this scenario should require ethics review. 163 
respondents left a comment detailing the reasons for the decision.  
Reasons for exempting the scenario: Those selecting to exempt the scenario from ethics review 
most frequently mentioned pre-existing consent (8 respondents), as “Consent to having blood drawn 
for the subjects should have already covered the potential use for future investigations.” Others (n=5) 
highlighted that the use of already collected tissues and samples is involved, and therefore this 
research “makes good use of waste”.  Several respondents (n=4) also focused on the low potential 
for increased risk, mentioning that the use poses “no additional harm.” 
Reasons for requiring ethics review for the scenario: Respondents most often (53 respondents) 
justified decisions to require ethics review for this scenario on consent grounds, stating that the 
patients’ “tissue belongs to them and must only be used for purposes that they consented to.” Others 
(n=47) emphasised the need for independent oversight provided by ethics review: “there should be 
checks in place to ensure this system is not abused, and that the patient’s interests are protected”. 
Review for scientific rigour (n=28) was thought to be needed, for example because the 
“circumstances of collection, storage, security, consent and disposal of samples should be 
documented and approved.” Some comments (n=20) raised the privacy or confidentiality aspects, 
stating that “privacy issues need to be assessed before approval.” 
Scenario 5: Quality assurance or audit project 
Condensed description of the survey scenario: Audit projects are done to produce information 
about whether care standards comply with national standards and practice guidelines. Those 
conducting the audit will report the findings to inform planned improvements locally, and they may 
also disseminate their findings through publication. 
Example A:  An audit and feedback project to reduce inappropriate prescribing. 
Of 190 responses to this question: 132 (69%) respondents stated this scenario should not require 
ethics review, and 58 (31%) respondents stated this scenario should require ethics review.   
Example B: Evaluation of door-to-needle time of patients with acute stroke, to improve treatment 
initiation. 
Of 189 responses to this question: 124 (66%) respondents stated this scenario should not require 
ethics review, and 65 (34%) respondents stated this scenario should require ethics review.   
Example C: Direct observation of nursing care for newborns, to identify missed elements of care. 
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Of 190 responses to this question: 87 (46%) respondents stated this scenario should not require 
ethics review, and 103 (54%) respondents stated this scenario should require ethics review.   
129 respondents left a comment detailing the reasons for the decision. 
Reasons for exempting the scenario: Respondents who supported exempting all 3 examples within 
this scenario, frequently did so based on study design (50 respondents), noting that quality 
improvement and “these sorts of audits should not require ethics review.” Others (n=13) based their 
decision on the low or negligible risk levels involved in the scenario, stating that it involves “[n]o risk 
to patients.” The scenario was also considered exempt on privacy/confidentiality grounds (n=11) as 
“none of these are taking any personal information.” Some respondents (n=9) also raised the issue of 
standard practice / routine care, emphasising that “all [scenarios are] assessing existing standard 
practice with no impact on those processes.”  
Reasons for requiring ethics review for the scenario: Those requiring ethics review for all 3 
examples within this scenario, were concerned that the scenarios involved direct observation of or 
interaction with patients (23 respondents), and stated that “any research involving direct 
relationship, even just observation, needs to be ethically reviewed.” Others were concerned about 
publishing issues (n=16), noting that “journals demand ethics approval.” The need for independent 
oversight was also provided as a reason (n=8) as “the participants are in a vulnerable position, either 
as employees of health services, or due to their status as patients (older, neonate, stroke) etc. Ethics 
review ensures consent and capacity obligations are met.”   
Scenario 6: Survey/questionnaire of patients, lay persons or carer (non-
professional) 
Condensed description of the survey scenario: A survey or questionnaire of patients, lay persons, or 
care providers, which does NOT include questions about highly sensitive areas (e.g. suicide, etc.) 
AND meets one the following criteria: 
Example A: Identity of respondents cannot be readily identified  
Of 220 responses to this question: 129 (59%) respondents stated this scenario should not require 
ethics review, and 91 (41%) respondents stated this scenario should require ethics review.   
Example B: Identity of respondents is known only to the research team, but not outside of the team. 
Of 221 responses to this question: 65 (29%) respondents stated this scenario should not require 
ethics review, and 156 (71%) respondents stated this scenario should require ethics review.   
148 respondents left a comment detailing the reasons for the decision. 
Reasons for exempting the scenario: Respondents supported exempting both examples within this 
scenario by the low potential for risk (16 respondents), noting that “risks are negligible.” Others 
(n=15) mentioned that the study design is “similar to post marketing / satisfaction surveys” and 
there is “no intervention.” Decision to exempt was often grounded in privacy/confidentiality 
considerations (n=12), as “privacy of participants is protected” or in the content of the 
questionnaires (n=12), as the “topics are not highly sensitive.”  
Reasons for requiring ethics review for the scenario: Comments supporting the requirement to 
undergo ethics review in both examples most often focused on privacy/confidentiality issues (46 
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respondents), emphasising that “just being anonymous may not mean that people cannot be 
identified.” Those highlighting the need for independent oversight (n=42) mentioned that 
“independent scrutiny in an ethical framework ensures protection of participants and their data.” 
Respondents also pointed out the need for a review of scientific rigour (n=13), noting that “HREC can 
help determine if proper care was taken in designing the study.”  
Scenario 7: Interview with patients, lay persons or carers (non-professional) 
Condensed description of the survey scenario: An interview (one-on-one or in a group), where 
consent has been obtained. The interview does NOT include questions about highly sensitive areas 
(e.g. suicide, etc.) AND meets one of the following criteria. 
Example A: Interviewee’s identity is known to the research team but not to the interviewer. 
 Of 195 responses to this question: 63 (32%) respondents stated this scenario should not require 
ethics review, and 132 (68%) respondents stated this scenario should require ethics review. 
Example B: Interviewee’s identity is known to the research team and the interviewer, but no one else. 
Of 195 responses to this question: 47 (24%) respondents stated this scenario should not require 
ethics review, and 148 (76%) respondents stated this scenario should require ethics review. 
141 respondents left a comment giving the reasons for the decision. 
Reasons for exempting the scenario: Respondents exempted both examples in this scenario mainly 
on the grounds of risk level and consent considerations. Respondents who based their decision on 
the level of risk (20 respondents), stated that “the administrative burden is not justified by the level 
of risk.” Respondents focused on the issues around consent (n=6) generally noted that “If the 
individuals are participating in the interview / FG [focus group] it implies that consent is present.”  
Reasons for requiring ethics review for the scenario: Respondents who required both examples 
within this scenario to undergo ethics review, often highlighted the need for independent oversight 
of this type of research (71 respondents): “external oversight for proposed research should be sought 
[as researchers] may not see potential issues with their research.” Some raised privacy/ 
confidentiality concerns (n=15), stating that “someone who understands the issues needs to review 
the arrangements to protect privacy.” Several (n=7) required the scenario to undergo review but 
other than an HREC review: one stated that they “come down in favour of a rapid, low-level review, 
but a review nonetheless.”  
Scenario 8: Professional staff providing opinion/views in their area of expertise 
Condensed description of the survey scenario: Professional staff (e.g. hospital, researchers) are 
asked as volunteers to share their views on their area of expertise, via a face to face interview or a 
written/online survey. 
Example A: Survey of general practitioners to prioritise systematic review topics.  
Of 226 responses to this question: 190 (84%) respondents stated this scenario should not require 
ethics review, and 36 (16%) respondents stated this scenario should require ethics review.   
Example B: A survey of systematic reviewers about systematic review software  
Of 227 responses to this question: 193 (85%) respondents stated this scenario should not require 
ethics review, and 34 (15%) respondents stated this scenario should require ethics review.   
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Example C: Interview with hospital physiotherapists about their experiences in implementing a 
specific therapy. 
Of 228 responses to this question: 91 (40%) respondents stated this scenario should not require 
ethics review, and 137 (60%) respondents stated this scenario should require ethics review.   
144 respondents left a comment detailing the reasons for the decision. 
Reasons for exempting the scenario: Respondents who supported exempting all 3 examples within 
this scenario did so most frequently because of low risk (37 respondents), noting that “none of these 
scenarios pose any risk of harms to anyone.” Others focused on study design (n=36), pointing out 
that these types of studies “are an essential part of quality improvement and enhance clinical 
practice.” Respondents also grounded their decision in privacy/confidentiality considerations (n=17) 
stating that “individual practitioner privacy [is] maintained.”  
Reasons for requiring ethics review for the scenario: Respondents who supported ethics review for 
all three examples, were frequently concerned about privacy/ confidentiality issues (43 
respondents), noting the involvement of “sensitive information regarding individuals.” Others (n=35) 
highlighted the need for independent oversight as “staff may be more likely to participate if there 
has been an independent review.” Respondents were also concerned about publishing issues (n=9), 
mentioning that “the presumption is that Ethics approval is needed when the results will be 
published.”  
Summary plot of scenario responses 
[insert figure 2 here] 
None of the presented scenarios were universally exempted from a requirement to undergo ethics 
review (see Figure 2). Professional staff providing opinion on the areas of their expertise or scope of 
practice were most often exempted (84–85% of responses, depending on the example); less 
frequently exempted were the quality assurance/audit activities (66–69% of responses, depending 
on the example). (See Appendix 4).  
Similarly, no scenario was universally required to undergo ethics reviews. Most commonly, 
respondents required studies of surplus samples and tissues (82% of responses) and “N of 1” studies 
in clinical practice (76% of responses) to undergo ethics reviews  
Probability of answering that a scenario requires ethics review by respondent 
type 
[insert figure 3 here] 
Probability of answering that an ethics review is required was the highest for respondents who were 
members of HRECs; those who were both HREC members and researchers were slightly less likely to 
require ethics review, but generally, the probabilities are nearly identical for these two groups. 
Researchers were less likely than both HREC members, and respondents who were both HREC 
members and researchers, to require an ethics review (Figure 3).  
13 
Overall, members of HRECs were 26% more likely to answer that ethics review was required than 
researchers, whilst the difference between those respondents who were members of HRECs and 
those who identified as both researchers and HREC members was 2% (indicating no strong 
difference). (See Appendix 3). 
Discussion  
This survey of researchers and members of research ethics committees in Australia revealed no 
unanimity about the circumstances in which research ethics review was needed.  Based on 
exemptions listed in guidance in other countries,(10) we identified two particular scenarios 
(interviews of professional staff about systematic review topics, and evaluation of systematic review 
software) – for which we found that 84% and 85%, respectively, agreed that ethics review was not 
required. Conversely, there was no scenario for which over 80% agreed that ethics review was 
required. Thus, for most scenarios (6 out of 8) there was no clear consensus on whether ethics 
review should be required. Views differed by the characteristics of the respondents: members of 
research ethics committees, and those who are both members of HRECs and researchers, were more 
likely than researchers who were not HREC members to indicate that ethics review was required for 
all 8 scenarios. 
A second important finding was on the impact of seeking ethics approval on research design and 
planning. Among respondents to whom this question applied, 43% reported changing their research 
plans because they anticipated obstacles resulting from the ethics review process, and 25% of 
decided to abandon research projects because of this. A well-functioning ethics review process 
should be stopping some types of particularly risky research, so some of these decisions to change or 
abandon projects may have been appropriate. However, the comments also showed that 
researchers are changing the research they do because of the ethics review process, rather than for 
sound ethical reasons. For example, proposed low risk student projects were abandoned because 
they could not be completed within a reasonable timeframe due to uncertainties and delays 
resulting from ethics review.  
Our survey had several limitations. Firstly, it was difficult to identify active researchers. As a proxy, 
we based our sample on researchers who had published recently. The response rate of around 20% 
was modest, but the high completion rates and large numbers of comments were testimony to the 
interest of these respondents. As with much survey research, respondents might have been more 
interested in the issues of ethics review (or had recent bad experiences), potentially limiting the 
applicability of our findings more widely. However, generalisability has been improved by using a 
random sampling approach rather than a snowball recruitment process. Secondly, there was 
evidence that our survey was forwarded outside our chosen population. This was suggested by 2 
respondents identifying themselves as HREC members only responding to the survey versions 
disseminated to researchers (versions A-D), and 12 researcher responses to surveys disseminated to 
HREC members (versions H1-H4). However, as the questions and scenarios were identical, this does 
not significantly undermine the validity of the findings. Thirdly, some of our results may not apply 
outside Australia as respondents either overtly, or sub-consciously, tailor their responses to the 
norms of the system they are used to working within. For instance, in the Netherlands and the UK, 
research only involving medical/healthcare staff and focused on their professional practice is exempt 
from formal ethics review, so if this survey were completed in these countries, higher proportions or 
respondents might state an exemption for this particular scenario.  Although repeating similar 
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surveys in other countries might help paint a fuller picture, it is likely that responses would need to 
be corrected for knowledge of existing practice in their locations/countries. 
Our findings are consistent with previous research, which has revealed considerable variability in 
opinions on the need for ethics review. A UK Delphi study achieved consensus on the level of ethical 
concern for only 14 of 46 questions. Interestingly there was also poor consensus on whether a 
project was classified as research or audit, and although most audits were considered to be of low 
ethics concern, some could be judged as high concern.(15) A three-country study of research ethics 
chairs presented with three cluster randomised trial scenarios also showed considerable 
variability.(16) Two of the scenarios – a cluster trial of mass media advertising campaigns to increase 
colorectal cancer screening and a cluster trial of an educational intervention targeting GPs – were 
split, with about half wanting full review and the others wanting either expedited or no review, 
suggesting low risk. 
This type of disagreement – both among the members of a single ethics committee and across 
different ethics committees – may lead to undesirable "ethics roulette."(6) This might be reduced by 
providing clear case examples in ethics guidance.  When researchers and practitioners are 
considering how to improve care, research ethics committees whose requirements impede these 
quality improvement initiatives should be challenged to justify their regulatory demands and the 
resulting efforts and delays that these will entail.  
Conclusion  
Our survey shows considerable differences between the researchers and members of ethics 
committees, about how best to serve the interests of patients and the public. This difference is 
reflected in conflicting comments left on our survey:  
“If you don’t have an ethics process/panel then there is no accountability for behaviour” – 
respondent who self-identified as a member of HREC only  
“It's time for this benighted country to catch up and begin to rein in these out-of-control 
ethics committees" – respondent who self-identified as a researcher only 
Ethics reviews endeavour to protect patient interests, but as we have shown previously, ethics 
review also has the capacity to do more harm than good.(6, 7) Of particular concern is the potential 
harm resulting from inhibiting or altering research that could benefit patients, such as quality 
improvement studies or interviews with professional staff.   
When there are uncertainties about which among alternative treatments can be expected to do 
more good than harm, the interests of patients are best served by evaluative research to reduce or 
resolve the uncertainties.  The same general principle, of conducting evaluative research to reduce 
or resolve the uncertainties, should be applied to ethics review.  
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